NCT03923127

Transitional Care Study 3

PJ-013483 FLAGSHIP Transitional Care Study 3

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 350 (actual)
• Sponsor: Philips Electronics Nederland B.V. acting through Philips CTO organization · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

In this study patients with elective surgery will wear two devices (HealthDot and Elan) after surgery in hospital and after discharge at home for up to 2 weeks (HealthDot) or 3 weeks (Elan). The HealthDot will measure heart rate, posture, activity and respiratory rate which are stored on the device as well as sent to Philips. The Elan device will measure PPG and accelerometer data which is transferred to Philips. The data collected will be used for algorithm development. Data will be analysed retrospectively and compared to readmission and adverse events to see if the events could have been predicted due to the collected data by the devices. No clinical decisions will be based on the measurements done during the study.

Conditions

• Surgery--Complications

Interventions

Type	Name	Description
OTHER	Elan and HealthDot	Patients with elective surgery will wear two devices (HealthDot and Elan) after surgery in hospital and after discharge at home for up to 2 weeks (HealthDot) or 3 weeks (Elan).

Timeline

• Start date: 2019-04-16
• Primary completion: 2020-08-17
• Completion: 2020-08-17
• First posted: 2019-04-22
• Last updated: 2020-08-28

Locations

1 site across 1 country: Netherlands